The healthcare and pharmaceutical reports of EMIS Insights covers the healthcare services and institutions, the relevant government policy and insurances, as well as the manufacturing and sales of medicines. We report on number of public and private hospitals, hospital beds, number of medical staff, number of patients and length of stay in hospitals and outpatient clinics. The mandatory and voluntary health insurances, as well as the lists of reimbursable medicines are being covered. The pharmaceutical sector coverage is split into manufacturing and distribution of branded and generic, as well as prescription and OTC drugs.
Each report contains in-depth analysis of the sector’s importance for the country’s economy, detailed statistics and infographics. The report includes executive summary, sector and subsector overviews, competitive and regulatory environment, as well as thorough company profiles of the top market players.
Thailand is the second-largest pharmaceutical market in South East Asia, with sales of THB 152.9bn in 2015. The pharmaceutical industry specialises in generic drug production and this is the largest segment on the market. Spending on health is ...READ MORE
In 2015, the total Hungarian healthcare expenditure amounted to HUF 2,373.4bn, or 7.04% of GDP. Public financing schemes made up 67.1% of the healthcare spending. By regional standards, the Hungarian health spending as a percentage of GDP is high, ...READ MORE
China is the world’s second-largest pharmaceutical market, after the US, and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large ageing ...READ MORE
China's healthcare system is hospital-centric, with public hospitals delivering approximately 90% of the inpatient and outpatient care consumed in the country today in both hospitals and basic medical institutions*. Nearly 40% of hospitals’ ...READ MORE
In 2015, Chile was the sixth largest pharmaceutical market in Latin America in terms of sales volume, with 278mn units sold, and the seventh biggest in terms of sales value, with USD 1.53bn, based on ex-factory prices (USD 2.32bn, based on retail ...READ MORE
The Russian healthcare and pharmaceutical sector is suffering under the impact of ongoing recession in the Russian economy and depressed domestic demand. The healthcare system is in dire need of financing as lower oil prices and a sharply devalued ...READ MORE
The Czech pharmaceutical sector is very attractive for international pharmaceutical manufacturers due to the favourable cost-efficiency ratio. The pharmaceutical sector generated a GVA of CZK 17.9bn in 2015, accounting for 0.4% of the total GVA. ...READ MORE
The Polish chemical industry represents around 4% of the value of the European chemical market according to MarketLine data for 2015, which covers specialty chemicals, commodity chemicals, agricultural chemicals and pharmaceutical chemicals. The ...READ MORE
China is the world’s second largest pharmaceutical market, after the U.S., and the largest producer and exporter of active pharmaceutical ingredients (APIs) globally. Since it is the world’s most populous country, with a large ageing ...READ MORE
China is the world's most populous country and the largest producer of grain, fruits and vegetables, which makes it also the world’s largest producer and consumer of fertilisers, required to satisfy its demand for crops and other agricultural ...READ MORE